Back to results
US 2003/0232844 A1Published application
Dihydrobenzopyrans, dihydrobenzothiopyrans, and tetrahydroquinolines for the treatment of cox-2 mediated disorders
AssigneePharmacia Corporation
InventorsDonald Rogier Jr, Jeffery Carter, John Talley
Life of this patent
Estimating the term…
Abstract
A class of dihydrobenzopyrans, dihydrobenzothiopyrans, tetrahydroquinolines, tetraydronaphthalenes, and analogs thereof, is described for use in treating cyclooxygenase-2 mediated disorders. Compounds of particular interest are defined by Formula (I) wherein X, A1, A2, A3, A4, R, R″, R1 and R2 are as described in the specification. 1
Claims21
A compound of Formula I
- 34
- wherein X is selected from O, S, CRcRb and NRa;
- wherein Ra is selected from hydrido, C1-C3-alkyl, phenyl-C1-C3-alkyl,(substituted phenyl)-C1-C3-alkyl, C1-C3-alkoxycarbonyl-C1-C3-alkyl and carboxy-C1-C6-alkyl;
- wherein each of Rb and Rc is independently selected from hydrido, C1-C3-alkyl, substituted or unsubstituted phenyl-C1-C3-alkyl, C1-C3-perfluoroalkyl, chloro, C1-C6-alkylthio, C1-C6-alkoxy, nitro, cyano and cyano-C1-C3-alkyl;
- or wherein CRbRc forms a 3-6 membered cycloalkyl ring;
- wherein R is selected from carboxyl, aminocarbonyl, C1-C6-alkylsulfonylaminocarbonyl and C1-C6-alkoxycarbonyl;
- wherein R″ is selected from hydrido, phenyl, thienyl, C1-C6-alkyl and C2-C6-alkenyl;
- wherein R1 is selected from C1-C3-perfluoroalkyl, chloro, C1-C6-alkylthio, C2-C6-alkoxy, nitro, cyano and cyano-C1-C3-alkyl;
- wherein R2 is one or more radicals independently selected from hydrido, halo, C1-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, halo-C2-C6-alkynyl, aryl-C1-C3-alkyl, aryl-C2-C6-alkynyl, aryl-C2-C6-alkenyl, C1-C6-alkoxy, methylenedioxy, C1-C6-alkylthio, C1-C6-alkylsulfinyl, aryloxy, arylthio, arylsulfinyl, heteroaryloxy, C1-C6-alkoxy-C1-C6-alkyl, aryl-C1-C6-alkoxy, heteroaryl-C1-C6-alkoxy, aryl-C1-C6-alkoxy-C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-haloalkoxy, C1-C6-haloalkylthio, C1-C6-haloalkylsulfinyl, C3-C6-haloalkylsulfonyl, C1-C3-(haloalkyl) —C1-C3-hydroxyalkyl, C1-C6-hydroxyalkyl, hydroxyimino-C1-C6-alkyl, C1-C6-alkylamino, arylamino, N-aryl-N—C1-C6-alkylamino, heteroarylamino, N-heteroaryl-N—C1-C6-alkylamino, nitro, cyano, amino, aminosulfonyl, C1-C6-alkylaminosulfonyl, arylaminosulfonyl, heteroarylaminosulfonyl, N-aryl-C1-C6-alkylaminosulfonyl, N-heteroaryl-C1-C6-alkylaminosulfonyl, heterocyclylsulfonyl, C1-C6-alkylsulfonyl, aryl-C1-C6-alkylsulfonyl, optionally substituted aryl, optionally substituted heteroaryl, aryl-C1-C6-alkylcarbonyl, heteroaryl-C1-C6-alkylcarbonyl, heteroarylcarbonyl, arylcarbonyl, aminocarbonyl, C1-C6-alkoxycarbonyl, formyl, C1-C6-haloalkylcarbonyl and C1-C6-alkylcarbonyl;
- and
- wherein the A ring atoms A1, A2, A3 and A4 are independently selected from carbon and nitrogen with the proviso that at least two of A1, A2 A3 and A4 are carbon;
- or wherein R2 together with ring A forms a radical selected from naphthyl, quinolyl, isoquinolyl, quinolizinyl, quinoxalinyl and dibenzofuryl;
- or an isomer or pharmaceutically acceptable salt thereof.
10 more elements
A compound of Formula II
- 35
- wherein R3 is selected from hydrido, C3-C3-alkyl, C1-C3-hydroxyalkyl, C1-C3-alkoxy and halo;
- wherein R4 is selected from hydrido, halo, C1-C4-alkyl, C1-C3-alkylthio, C1-C3-haloalkyl, amino, aminosulfonyl, C1-C3-alkylsulfonyl, C1-C3-alkylsulfinyl, C1-C3-alkoxy-C1-C3-alkyl, C1-C3-alkylcarbonyl, formyl, cyano, C1-C3-haloalkylthio, substituted or unsubstituted phenylcarbonyl, C1-C3-haloalkoxy, C1-C3-alkoxy, aryl-C1-C3-alkylcarbonyl, di-C1-C3-alkylaminosulfonyl, C1-C3-alkylaminosulfonyl, aryl-C1-C3-alkylaminosulfonyl, 5- or 6-heteroaryl-C1-C3-alkylaminosulfonyl, 5- or 6-membered heteroaryl, C1-C3-hydroxyalkyl, substituted or unsubstituted phenyl and 5- or 6-membered nitrogen-containing heterocyclylsulfonyl;
- wherein R5 is selected from hydrido, C1-C4-alkyl, halo, C1-C3-haloalkyl, C1-C4-hydroxyalkyl, C2-C3-alkynyl, C2-C3-alkenyl, C1-C3-alkoxy, phenoxy, phenoxy independently substituted with one or more radicals selected from C1-C3-haloalkyl, nitro, carboxyl, C1-C3-haloalkoxy, C1-C3-alkoxy, cyano, C1-C3-alkyl and halo, naphthyloxy, naphthyloxy substituted with one or more halo radicals, phenylthio, phenylthio substituted with one or more halo radicals, phenylsulfinyl, phenylsulfinyl substituted with one or more halo radicals, phenylsulfonyl, phenylsulfonyl substituted with one or more halo radicals, pyridinyloxy, pyridinyloxy substituted with one or more halo radicals, and phenyl;
- and
- wherein R6 is selected from hydrido, halo, cyano, hydroxyiminomethyl, C1-C3-hydroxyalkyl, C2-C3-alkynyl, phenyl-C2-C3-alkynyl, C1-C4-alkyl, C1-C3-alkoxy, formyl and phenyl;
- or an isomer or pharmaceutically acceptable salt thereof.
4 more elements
A compound of Formula III
- 36
- wherein Ra is selected from hydrido and lower aralkyl;
- wherein R3 is selected from hydrido, C3-C3-alkyl, C1-C3-hydroxyalkyl, C1-C3-alkoxy and halo;
- wherein R4 is selected from hydrido, halo, C1-C4-alkyl, C1-C3-alkylthio, C1-C3-haloalkyl, amino, aminosulfonyl, C1-C3-alkylsulfonyl, C1-C3-alkylsulfinyl, C1-C3-alkoxy-C1-C3-alkyl, C1-C3-alkylcarbonyl, formyl, cyano, C1-C3-haloalkylthio, substituted or unsubstituted phenylcarbonyl, C1-C3-haloalkoxy, C1-C3-alkoxy, aryl-C1-C3-alkylcarbonyl, di-C1-C3-alkylaminosulfonyl, C1-C3-alkylaminosulfonyl, aryl-C1-C3-alkylaminosulfonyl, 5- or 6-heteroaryl-C1-C3-alkylaminosulfonyl, 5- or 6-membered heteroaryl, C1-C3-hydroxyalkyl, substituted or unsubstituted phenyl and 5- or 6-membered nitrogen-containing heterocyclylsulfonyl;
- wherein R5 is selected from hydrido, C3-C4-alkyl, halo, C1-C3-haloalkyl, C1-C4-hydroxyalkyl, C2-C3-alkynyl, C2-C3-alkenyl, C1-C3-alkoxy, phenoxy, phenoxy independently substituted with one or more radicals selected from C1-C3-haloalkyl, nitro, carboxyl, C1-C3-haloalkoxy, C1-C3-alkoxy, cyano, C1-C3-alkyl and halo, naphthyloxy, naphthyloxy substituted with one or more halo radicals, phenylthio, phenylthio substituted with one or more halo radicals, phenylsulfinyl, phenylsulfinyl substituted with one or more halo radicals, phenylsulfonyl, phenylsulfonyl substituted with one or more halo radicals, pyridinyloxy, pyridinyloxy substituted with one or more halo radicals, and phenyl;
- and
- wherein R6 is selected from hydrido, halo, cyano, hydroxyiminomethyl, C1-C3-hydroxyalkyl, C2-C3-alkynyl, phenyl-C2-C3-alkynyl, C1-C4-alkyl, C1-C3-alkoxy, formyl and phenyl;
- or an isomer or pharmaceutically acceptable salt thereof.
5 more elements
A compound of Formula IV
- 37
- wherein R3 is selected from hydrido, C1-C3-alkyl, C1-C3-hydroxyalkyl, C1-C3-alkoxy and halo;
- wherein R4 is selected from hydrido, halo, C1-C4-alkyl, C1-C3-alkylthio, C1-C3-haloalkyl, amino, aminosulfonyl, C1-C3-alkylsulfonyl, C1-C3-alkylsulfinyl, C1-C3-alkoxy-C1-C3-alkyl, C1-C3-alkylcarbonyl, formyl, cyano, C1-C3-haloalkylthio, substituted or unsubstituted phenylcarbonyl, C1-C3-haloalkoxy, C1-C3-alkoxy, aryl-C1-C3-alkylcarbonyl, di-C1-C3-alkylaminosulfonyl, C1-C3-alkylaminosulfonyl, aryl-C1-C3-alkylaminosulfonyl, 5- or 6-heteroaryl-C1-C3-alkylaminosulfonyl, 5- or 6-membered heteroaryl, C1-C3-hydroxyalkyl, substituted or unsubstituted phenyl and 5- or 6-membered nitrogen-containing heterocyclylsulfonyl;
- wherein R5 is selected from hydrido, C1-C4-alkyl, halo, C1-C3-haloalkyl, C1-C4-hydroxyalkyl, C2-C3-alkynyl, C2-C3-alkenyl, C1-C3-alkoxy, phenoxy, phenoxy independently substituted with one or more radicals selected from C1-C3-haloalkyl, nitro, carboxyl, C1-C3-haloalkoxy, C1-C3-alkoxy, cyano, C1-C3-alkyl and halo, naphthyloxy, naphthyloxy substituted with one or more halo radicals, phenylthio, phenylthio substituted with one or more halo radicals, phenylsulfinyl, phenylsulfinyl substituted with one or more halo radicals, phenylsulfonyl, phenylsulfonyl substituted with one or more halo radicals, pyridinyloxy, pyridinyloxy substituted with one or more halo radicals, and phenyl;
- and
- wherein R6 is selected from hydrido, halo, cyano, hydroxyiminomethyl, C1-C3-hydroxyalkyl, C2-C3-alkynyl, phenyl-C2-C3-alkynyl, C1-C4-alkyl, C1-C3-alkoxy, formyl and phenyl;
- or an isomer or pharmaceutically acceptable salt thereof.
4 more elements
A process for the preparation of compounds of compound of Formula I
- 38
- wherein X is selected from O, S, CRcRb and NRa;
- wherein Ra is selected from hydrido, C1-C3-alkyl, (optionally substituted phenyl)-C1-C3-alkyl, alkoxycarbonylalkyl and carboxy-C1-C6-alkyl;
- wherein each of Rb and Rc is independently selected from hydrido, C1-C3-alkyl, phenyl-C1-C3-alkyl, C1-C3-perfluoroalkyl, chloro, C1-C6-alkylthio, C1-C6-alkoxy, nitro, cyano and cyano-C1-C3-alkyl;
- or wherein CRbRc forms a 3-6 membered cycloalkyl ring;
- wherein R is selected from carboxyl, aminocarbonyl, C1-C6-alkylsulfonylaminocarbonyl and C1-C6-alkoxycarbonyl;
- wherein R″ is selected from hydrido, phenyl, thienyl, C1-C6-alkyl and C2-C6-alkenyl;
- wherein R1 is selected from C1-C3-perfluoroalkyl, chloro, C1-C6-alkylthio, C1-C6-alkoxy, nitro, cyano and cyano-C1-C3-alkyl;
- wherein R2 is one or more radicals independently selected from hydrido, halo, C1-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, halo-C2-C6-alkynyl, aryl-C1-C3-alkyl, aryl-C2-C6-alkynyl, aryl-C2-C6-alkenyl, C1-C6-alkoxy, methylenedioxy, C1-C6-alkylthio, C1-C6-alkylsulfinyl, aryloxy, arylthio, arylsulfinyl, heteroaryloxy, C1-C6-alkoxy-C1-C6-alkyl, aryl-C1-C6-alkoxy, heteroaryl-C1-C6-alkoxy, aryl-C1-C6-alkoxy-C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-haloalkoxy, C1-C6-haloalkylthio, C1-C6-haloalkylsulfinyl, C1-C6-haloalkylsulfonyl, C1-C3— (haloalkyl-C1-C3-hydroxyalkyl, C1-C6-hydroxyalkyl, hydroxyimino-C1-C6-alkyl, C1-C6-alkylamino, arylamino, aryl-C1-C6-alkylamino, heteroarylamino, heteroaryl-C1-C6-alkylamino, nitro, cyano, amino, aminosulfonyl, C1-C6-alkylaminosulfonyl, arylaminosulfonyl, heteroarylaminosulfonyl, aryl-C1-C6-alkylaminosulfonyl, heteroaryl-C1-C6-alkylaminosulfonyl, heterocyclylsulfonyl, C1-C6-alkylsulfonyl, aryl-C1-C6-alkylsulfonyl, optionally substituted aryl, optionally substituted heteroaryl, aryl-C1-C6-alkylcarbonyl, heteroaryl-C3-C6-alkylcarbonyl, heteroarylcarbonyl, arylcarbonyl, aminocarbonyl, C1-C6-alkoxycarbonyl, formyl, C1,C6-haloalkylcarbonyl and C1-C6-alkylcarbonyl;
- and
- wherein the A ring atoms A1, A2, A3 and A4 are independently selected from carbon and nitrogen with the proviso that at least two of A1, A2, A3 and A4 are carbon;
- or wherein R2 together with ring A forms a radical selected from naphthyl, quinolyl, isoquinolyl, quinolizinyl, quinoxalinyl and dibenzofuryl;
- or an isomer or pharmaceutically acceptable salt thereof;
- Said process comprising reducing a compound of Formula 41.
11 more elements
Dependencies are inferred from the claim text.